PharmaVoice 100 by Marie Jung The July/August Special Issue of PharmaVoice Magazine features 100 individuals designated by the publication as some of the “Most Inspiring” people in the life sciences, and the event celebrating the honorees took place in New York City in September. Influenced by the inclusion of adjectives Read more
MedCity ENGAGE patient engagement conference makes successful 1st time splash in San Diego
by Marie Jung Lucky for us, MedCity moved their annual patient engagement conference, ENGAGE, to San Diego from Washington, D.C., adding to our fall bumper crop of health related conferences. ENGAGE took place at the La Jolla Mariott Hotel on October 18th and 19th. It was a small, but very Read more
The realities of Phase 1 clinical trials may not match patient expectations
Almost one-half of patients referred to a phase 1 clinical trial predicted tumor shrinkage as a result of participating in the phase I clinical trial. These rates conflict with the typical phase I response rates of 4% to 20%, and this discrepancy demonstrates the challenges facing patients and healthcare professionals during their interactions in phase I studies. (cancer network.com)
Communicating with participants during the conduct of multi-center clinical trials
Teleconferences provide a convenient way to communicate with trial participants and can be used during the conduct of clinical trials to convey study progress and other information. For multi-site trials, teleconferences enable participants to engage directly with study leadership and to ask questions. Survey respondents were highly satisfied with the group teleconference experience. (Clinical Trials)
Mexican-American perspectives on participation in clinical trials: A qualitative study
Results suggest that lack of knowledge and understanding of clinical trials leads to misunderstanding about research, including fears and lack of trust. Participants indicated that fears related to perceived experimentation, harm, immigration status, and lack of clinical trial opportunities within their communities were barriers to participation. On the other hand, free healthcare access, helping family members in the future, and monetary incentives could facilitate participation. (Contemp Clin Trials Commun)
Few people of color in ‘artificial pancreas’ tests
For years, doctors and patients have been waiting for the arrival of an “artificial pancreas” to take the guesswork out of life with diabetes by measuring blood sugar levels and automatically delivering the amount of insulin needed to keep the disease in check. But now that this experimental device is close to becoming reality, a new study suggests that tests to date have largely ignored a big segment of the patient population that might use it – people of color. (Reuters)
June 21 SDCRN program blog. “Implementing patient-centric strategies in a natural history trial: a case study”
Here is blog Report from SDCRN + San Diego ACRP Chapter joint program on June 21 IMPLEMENTING PATIENT-CENTRIC STRATEGIES IN A NATURAL HISTORY TRIAL: A CASE STUDY Blog by Roberta Alexander, Ph.D. The San Diego Clinical Research Network (SDCRN) (Clinical Research News, Developments, Resources & More) and the San Diego Read more
June 21 SDCRN program slides. “Implementing patient-centric strategies in a natural history trial: a case study”
Here are the presentation slides from the joint meeting of San Diego Clinical Research Network and Greater San Diego Area Chapter of ACRP on June 21. IMPLEMENTING PATIENT-CENTRIC STRATEGIES IN A NATURAL HISTORY TRIAL: A CASE STUDY Speaker: Jacqui Blem, Senior Director, Clinical Operations, Regulus Therapeutics Patient centricity is one of the Read more
SDCRN June 21 mtg. Blog. “Implementing patient-centric strategies in clinical trials
Implementing Patient-Centric Strategies in a Natural History Trial: A Case Study Blog by Roberta Alexander, Ph.D. The San Diego Clinical Research Network (SDCRN) (Clinical Research News, Developments, Resources & More) and the San Diego Chapter of the Association of Clinical Research Professionals (ACRP) (http://www.acrpnet.org/) co-organized an event on June 21st, Read more
ClinOps has important role to play in improving the patient experience
Patient Centricity: ClinOps Taking the Lead
Patient centricity continues to gain steam as a critical component to any well-run clinical trial…As a result, Clinical Operations (ClinOps) has only been a small part of this discussion. As a 25-year veteran in the industry, my perspective is that ClinOps has a critical role to play in improving the way pharma is partnering with patients to execute better and more efficient clinical trials. (Drug Discovery and Development Magazine)